| 000 | 01671 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250511215314.0 | ||
| 264 | 0 | _c19910401 | |
| 008 | 199104s 0 0 eng d | ||
| 022 | _a0030-2414 | ||
| 024 | 7 |
_a10.1159/000226907 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMolino, A | |
| 245 | 0 | 0 |
_aThe antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study. _h[electronic resource] |
| 260 |
_bOncology _c1991 |
||
| 300 |
_a111-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiemetics _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLorazepam _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetoclopramide _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPyrrolidines _xadministration & dosage |
| 650 | 0 | 4 |
_aVomiting _xprevention & control |
| 700 | 1 | _aGuglielmo, L | |
| 700 | 1 | _aAzzolini, M E | |
| 700 | 1 | _aBiondani, P | |
| 700 | 1 | _aCapelli, M C | |
| 700 | 1 | _aGrandinetti, A | |
| 700 | 1 | _aGriso, C | |
| 700 | 1 | _aMartinelli, G | |
| 700 | 1 | _aMartini, N | |
| 700 | 1 | _aZanotti, R | |
| 773 | 0 |
_tOncology _gvol. 48 _gno. 2 _gp. 111-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000226907 _zAvailable from publisher's website |
| 999 |
_c2004112 _d2004112 |
||